Growth hormone receptor in VGLUT2 or Sim1 cells regulates glycemia and insulin sensitivity

Autor(es):Mostrar menos -

Tavares, Mariana R. ; dos Santos, Willian O. ; Amaral, Andressa G. ; List, Edward O. ; Kopchick, John J. ; Alves, Guilherme A. ; Frazao, Renata ; dos Santos, Jessica D. M. ; Cruz, Alessandra G. ; Camporez, Joao Paulo ; Donato Jr, Jose

• Tipo de documento: Artigo Científico
• Fonte: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA; v. 121, n. 52, p. 11-pg., 2024-12-24.

Resumo

Growth hormone (GH) has several metabolic effects, including a profound impact on glucose homeostasis. For example, GH oversecretion induces insulin resistance and increases the risk of developing diabetes mellitus. Here, we show that GH receptor (GHR) ablation in vesicular glutamate transporter 2 (VGLUT2)- expressing cells, which comprise a subgroup of glutamatergic neurons, led to a slight decrease in lean body mass without inducing changes in body adiposity. VGLUT2 triangle GHR mice exhibited reduced glycemia and improved glucose tolerance and insulin sensitivity. Among different glutamatergic neuronal populations, we found that GHR inactivation in Sim1-expressing cells recapitulated the phenotype observed in VGLUT2 triangle GHR mice. Furthermore, Sim1 triangle GHR" mice exhibited reduced endogenous glucose production and improved hepatic insulin sensitivity without alterations in whole- body or muscle glucose uptake. Sim1 triangle GHR mice were protected against acute but not chronic diabetogenic effects of exogenous GH administration. Pharmacological activation of ATP- sensitive potassium channels in the brain normalized blood glucose levels in Sim1 triangle GHR mice. In conclusion, the absence of GHR signaling in VGLUT2/Sim1- expressing cells causes a persistent reduction in glycemia and improves hepatic insulin sensitivity. Central glucose- sensing mechanisms are likely involved in the reduced glycemia exhibited by Sim1 triangle GHR mice. The current findings uncover a mechanism involved in the effects of GHR signaling in regulating glucose homeostasis. (AU)

• Processo FAPESP: 20/10102-9 - Estudo dos efeitos induzidos pela ablação do receptor de GH em neurônios da área hipotalâmica lateral
• Beneficiário: Mariana Rosolen Tavares
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado
• Processo FAPESP: 21/08792-0 - Envolvimento do sistema kisspeptina hipotalâmico mediante alterações da secreção do hormônio do crescimento
• Beneficiário: Guilherme Andrade Alves
• Modalidade de apoio: Bolsas no Brasil - Doutorado
• Processo FAPESP: 18/04956-5 - Impacto do receptor de estrogênio alpha na Doença Hepática Gordurosa não Alcoólica e metabolismo energético do fígado
• Beneficiário: João Paulo Gabriel Camporez
• Modalidade de apoio: Auxílio à Pesquisa - Jovens Pesquisadores
• Processo FAPESP: 22/11262-5 - Envolvimento de neurônios kisspeptinérgicos hipotalâmicos em disfunções reprodutivas devido a alterações do eixo GHIGF-1
• Beneficiário: Renata Frazão
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 20/01318-8 - Sistema nervoso central como um alvo do hormônio do crescimento para a regulação de múltiplas funções biológicas
• Beneficiário: Jose Donato Junior
• Modalidade de apoio: Auxílio à Pesquisa - Temático